Covid-19 vaccine made by Pfizer Inc. and BioNTech SE, U.S. health officials said, opening an important new phase of the U.S.
immunization effort.The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14 to 0, with one recusal, on Wednesday to support the two-dose vaccine’s emergency authorization after it was cleared by the Food and Drug Administration on Monday.